Information about Bioexpand
My details
*
*
*

Bioexpand (SRL)

BE 0630.855.138

Avenue Latérale 143, 1180 Uccle

Company information

Status
Active

Enterprise number

BE0630.855.138

VAT liability
Yes
Established
27-05-2015
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Bioexpand

2024 2023 2022 2021
Profit/Loss € 47,221 148 % € 19,059 -21 % € 24,100 -41 % € 40,942
Equity € 313,562 18 % € 266,341 8 % € 247,282 11 % € 223,183
Gross margin € 76,792 158 % € 29,729 -28 % € 41,570 -32 % € 61,410

Publications from Bioexpand

Date Publication
01-03-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
30-11-2016 Registered Office (FR)
29-05-2015 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Bioexpand?
The VAT number of Bioexpand is BE 0630.855.138.
Wat is the PEPPOL ID of Bioexpand?
There is no information available about the PEPPOL ID of Bioexpand or the company is not yet registered on the PEPPOL network.
When was Bioexpand founded?
Bioexpand was founded on 27-05-2015.
What is the address of Bioexpand?
The current registered office of Bioexpand is located at Avenue Latérale 143, 1180 Uccle.
When was the last time Bioexpand filed their annual financial statements?
The most recent financial statements of Bioexpand were filed on 18-10-2025.
How many employees does Bioexpand have?
There are currently no employees working at Bioexpand or no workforce information is available.
What is the annual turnover of Bioexpand?
At the time of its most recent financial statements, Bioexpand did not publish any turnover figures. Bioexpand reported a gross margin of €76,792.08.

Sources